Pharmaceutical

EC approves extension of indication for Janssen-Cilag’s Darzalex

The European Commission (EC) has granted approval for the extension of indication for Janssen-Cilag International’s Darzalex SC formulation.

Apr 8, 2025 - 06:00
EC approves extension of indication for Janssen-Cilag’s Darzalex
The European Commission (EC) has granted approval for the extension of indication for Janssen-Cilag International’s Darzalex SC formulation.
Read the original article

Tags:

Previous Article

Africa: The clinical impact of the US withdrawal from WHO and USAID

Next Article

AD/PD 2025: Reporting of first real-world data for Leqembi focuses on operationa...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Are European biopharma manufacturers ‘nearshoring’?

Are European biopharma manufacturers ‘nearshoring’?

Mar 5, 2025

STAT+: House panel takes first steps toward reining in hospitals with ‘site-neutral’ changes

STAT+: House panel takes first steps toward reining in ...

May 17, 2023

Orbit and Evergreen partner to advance radiopharmaceuticals development

Orbit and Evergreen partner to advance radiopharmaceuti...

Apr 4, 2023